(Q34311382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Innovative treatments for pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

H Hörig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H L Kaufman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

Surgical Clinics of North America

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

715-739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

Generation of Stable CD4+and CD8+T Cell Lines from Patients Immunized withrasOncogene-Derived Peptides Reflecting Codon 12 Mutations

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Dendritic Cells Pulsed with CEA Peptide Induce CEA-Specific CTL with Restricted TCR Repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

HLA Binding Characteristics and Generation of Cytotoxic Lymphocytes against Peptides Derived from Oncogenic Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

p53 overexpression in lymph node metastases predicts clinical outcome in ductal pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

II. Contribution to the Knowledge of Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Implications of the Human Genome Project for medical science.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Relationship of family cancer history to the expression of P53, P21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Current issues in cancer vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Angiostatin generation by human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Pancreatic cancer: a review of emerging therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Antigen-processing machinery breakdown and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Cytokine production by human soft tissue sarcomas: implications for immunosuppression within the tumour bed

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

HLA class I expression on human cancer cells. Implications for effective immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Production of monoclonal antibodies to serum antigens in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Carcinoembryonic antigen gene family: molecular biology and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

c‐erbB‐2 anti‐sense phosphorothioate oligodeoxynucleotides inhibit growth and serum‐induced cell spreading of p185c‐erbB‐2‐overexpressing ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970157-2

7 January 2021

10.1016/S0039-6109(05)70157-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11459285%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference